| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $77,763,061 ) (Continued on the next page) |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 010 | 2 | NIH | 3/2/2026 | $154,789 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 010 | 2 | NIH | 3/2/2026 | -$154,789 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 009 | 2 | NIH | 3/2/2026 | $578,469 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 009 | 2 | NIH | 3/2/2026 | -$578,469 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 008 | 2 | NIH | 3/2/2026 | $267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 008 | 2 | NIH | 3/2/2026 | -$267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 007 | 2 | NIH | 3/2/2026 | $338,964 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 007 | 2 | NIH | 3/2/2026 | -$338,964 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 006 | 2 | NIH | 3/2/2026 | $102,360 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 006 | 2 | NIH | 3/2/2026 | -$102,360 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM128731 | Structure and Function of the Essential Cell Cycle Regulator Cdc34 | 000 | 9 | NIH | 2/12/2026 | $319,302 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01AG022307 | Center for Testing Potential Anti-Aging Interventions | 000 | 23 | NIH | 6/23/2026 | $1,546,778 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 001 | 2 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 000 | 2 | NIH | 2/5/2026 | $39,070 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R34HL177446 | TranExamic Atomized for Pediatric post-Operative Tonsillectomy hemorrhage (TEAPOT) | 000 | 2 | NIH | 6/23/2026 | $356,249 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 000 | 5 | NIH | 3/5/2026 | $527,072 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI185790 | Lymphotoxin-dependent control of long COVID | 000 | 1 | NIH | 2/13/2026 | $234,715 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH127216 | Neural connectivity before and after each of the three treatment phases of trauma-focused therapy for adolescent posttraumatic stress | 000 | 5 | NIH | 1/27/2026 | $775,052 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM160303 | Molecular Architecture and Function of synaptic AMPA receptor complexes | 000 | 2 | NIH | 6/26/2026 | $433,125 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI045050 | Characterization of SLE-susceptibility loci on mouse chromosome 1 | 000 | 26 | NIH | 5/26/2026 | $721,482 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL175081 | Characterize TMEM94 as ER Mg2+ uptake machinery and pathophysiological consequences. | 000 | 2 | NIH | 5/12/2026 | $529,902 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 000 | 4 | NIH | 3/9/2026 | $528,581 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141631 | Repair of DNA ends with adducts | 000 | 4 | NIH | 2/9/2026 | $310,000 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE033455 | TRPM2-mediated immune activation initiates radiation-induced loss of oral function | 000 | 2 | NIH | 3/27/2026 | $622,744 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA293672 | Developing purinergic receptor inverse agonists for treating triple negative breast cancer | 000 | 2 | NIH | 3/5/2026 | $567,600 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA283749 | The role of tumor-macrophage hybrid cells in prostate cancer metastasis | 002 | 3 | NIH | 6/17/2026 | $0 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA283749 | The role of tumor-macrophage hybrid cells in prostate cancer metastasis | 001 | 3 | NIH | 4/29/2026 | $8,575 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA283749 | The role of tumor-macrophage hybrid cells in prostate cancer metastasis | 000 | 3 | NIH | 4/21/2026 | $628,593 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA249305 | The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC | 000 | 7 | NIH | 3/4/2026 | $375,936 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA244261 | Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission | 000 | 7 | NIH | 2/27/2026 | $332,169 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK097554 | Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes | 000 | 13 | NIH | 3/24/2026 | $684,914 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25DE032518 | Dental Research Intensive Program for Undergradate Students | 000 | 2 | NIH | 1/29/2026 | $134,934 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 001 | 4 | NIH | 2/6/2026 | $42,727 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 000 | 4 | NIH | 1/30/2026 | $384,558 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3AG090675 | Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project | 002 | 2 | NIH | 3/25/2026 | $274,600 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3AG090675 | Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project | 001 | 2 | NIH | 3/9/2026 | $22,954 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3AG090675 | Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project | 000 | 2 | NIH | 3/4/2026 | $206,588 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK140144 | Glycemic and Weight Loss Effects of Semaglutide in Subjects After Spinal Cord Injury and Type 2 Diabetes | 000 | 3 | NIH | 6/9/2026 | $700,873 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM163922 | Protein Intrinsic Disorder in Genome Regulation | 000 | 1 | NIH | 4/8/2026 | $378,000 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG081362 | Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease | 000 | 2 | NIH | 3/9/2026 | $771,678 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R33AT012117 | Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons | 000 | 3 | NIH | 7/3/2026 | $306,574 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R13AG099734 | Leveraging the Trusted Role of Churches to Disseminate Research, Resources, and Support to Communities Disproportionately Affected by Dementia | 000 | 1 | NIH | 2/19/2026 | $50,000 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK143234 | Metabolite Markers of Diabetic Kidney Disease | 000 | 1 | NIH | 4/17/2026 | $825,255 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | S10OD040222 | Illumina NovaSeq X Sequencing System | 000 | 1 | NIH | 5/7/2026 | $750,000 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32AI197576 | Unleashing Natural Immunity Against Epstein-Barr Virus | 002 | 1 | NIH | 4/17/2026 | $0 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32AI197576 | Unleashing Natural Immunity Against Epstein-Barr Virus | 001 | 1 | NIH | 4/17/2026 | $0 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32AI197576 | Unleashing Natural Immunity Against Epstein-Barr Virus | 000 | 1 | NIH | 4/17/2026 | $76,780 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25AG095799 | Advancing cross-national research on aging and cognitive function: English/Spanish courses with the Mexican Health and Aging Study and HRS/HCAP global partner studies | 001 | 2 | NIH | 6/23/2026 | $366,354 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM163544 | Spatiotemporal regulation of DNA metabolism pathways | 000 | 1 | NIH | 5/7/2026 | $433,125 |
|
